Medical Economics February 24, 2025
Key Takeaways
- OpenEvidence secured a $1 billion valuation with Series A funding led by Sequoia Capital, raising over $100 million in total capital.
- A partnership with NEJM Group allows OpenEvidence to integrate decades of peer-reviewed medical research into its AI models.
- The platform supports physicians by synthesizing evidence-based insights in real time, addressing the complexity of modern medical knowledge.
- OpenEvidence plans to expand its team of AI scientists and develop medical domain-specific Large Language Models for clinical applications.
OpenEvidence secures a $1B valuation, and access to decades of NEJM content, multimedia.
OpenEvidence, an artificial intelligence (AI)-driven clinical decision support platform, has secured a $1 billion valuation following a Series A funding round led by Sequoia Capital. The investment...
Today's Sponsors
Today's Sponsor